the world order of asthma apps has began, page-5

If you exclude the payment due to Qualcomm, then ISN seem funded for atleast this calander year. And I suspect the Qualcomm payment will end up being shares.

I agree you shouldn't base a company around an app. If you purposely set out to do that then no point staying in the biotech sector. You'd do better releasing a game like Angry Birds.

But we do need to give ISN time to integrate the app with existing hardware and see if they can market it in a way that is profitable. Ofcourse it's a hard sell. They are on record as saying Wheezometer is overpriced and struggling without insurance rebates.

What does that mean when now they suddenly need to sell an expensive Wheezometer plus an app plus monthly billing. The only way it might work is to incorporare the hardware in the monthly fee and sign a 12month contract?